Economic outcomes of nutritional interventions with functional bioactive compounds
暂无分享,去创建一个
[1] R. Cherecheș,et al. Use and effectiveness of behavioural economics in interventions for lifestyle risk factors of non-communicable diseases: a systematic review with policy implications , 2018, Perspectives in public health.
[2] D. Soffer,et al. Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids , 2017, Current Atherosclerosis Reports.
[3] H. Gage,et al. The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study , 2017, The European Journal of Health Economics.
[4] Jared G. Carlberg,et al. Canadian Potential Healthcare and Societal Cost Savings from Consumption of Pulses: A Cost-Of-Illness Analysis , 2017, Nutrients.
[5] F. van der Haar,et al. The Use and Interpretation of Sodium Concentrations in Casual (Spot) Urine Collections for Population Surveillance and Partitioning of Dietary Iodine Intake Sources , 2016, Nutrients.
[6] Stacey Fuller,et al. New Horizons for the Study of Dietary Fiber and Health: A Review , 2016, Plant Foods for Human Nutrition.
[7] M. Maziarz,et al. Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon , 2015, Metabolites.
[8] Leila Posenato Garcia,et al. Resenha do livro Saúde Brasil 2014: uma análise da situação de saúde e das causas externas , 2015 .
[9] Jared G. Carlberg,et al. Cost-of-illness analysis reveals potential healthcare savings with reductions in type 2 diabetes and cardiovascular disease following recommended intakes of dietary fiber in Canada , 2015, Front. Pharmacol..
[10] O. D. Rangel-Huerta,et al. A Systematic Review of the Efficacy of Bioactive Compounds in Cardiovascular Disease: Phenolic Compounds , 2015, Nutrients.
[11] J. Schmier,et al. Cost Savings of Reduced Constipation Rates Attributed to Increased Dietary Fibre Intakes in Europe: A Decision-Analytic Model , 2015 .
[12] F. Hu,et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies , 2014, BMJ : British Medical Journal.
[13] J. Schmier,et al. Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model , 2014, BMC Public Health.
[14] Jared G. Carlberg,et al. Health economics and nutrition: a review of published evidence. , 2012, Nutrition reviews.
[15] B. Arondekar,et al. Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. , 2011, The American journal of cardiology.
[16] L. Niskanen,et al. Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies , 2011, European Journal of Clinical Nutrition.
[17] Jared G. Carlberg,et al. Economic valuation of the potential health benefits from foods enriched with plant sterols in Canada , 2010, Food & nutrition research.
[18] J. Hutton,et al. Nutrition economics – characterising the economic and health impact of nutrition , 2010, British Journal of Nutrition.
[19] Kirsten Bibbins-Domingo,et al. Projected effect of dietary salt reductions on future cardiovascular disease. , 2010, The New England journal of medicine.
[20] V. Fulgoni,et al. Potential Health Benefits and Medical Cost Savings from Calorie, Sodium, and Saturated Fat Reductions in the American Diet , 2009, American journal of health promotion : AJHP.
[21] H. Gylling,et al. Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[22] L. Annemans,et al. A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction , 2006, PharmacoEconomics.
[23] A. Gerber,et al. Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction , 2006, The European Journal of Health Economics.
[24] J. Schmier,et al. The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events. , 2006, Managed care.
[25] R. Mensink,et al. Metabolic effects of plant sterols and stanols (Review). , 2003, The Journal of nutritional biochemistry.
[26] N. Novo,et al. Health economics and health preference concepts to orthopedics practitioners , 2014, Acta ortopedica brasileira.
[27] A. Feigl,et al. The Global Economic Burden of Noncommunicable Diseases , 2012 .
[28] F. Valagussa,et al. Cost-Effectiveness Analysis of n-3 Polyunsaturated Fatty Acids (PUFA) after Myocardial Infarction , 2012, PharmacoEconomics.